Medi Labz

Rhythm notes · ECG Simulator

Supraventricular tachycardia (SVT)

Clinical review pending: written from the sources below, not yet checked by a clinician. Updated 2026-11-22.

Wave size
Lead II · small box: 40 ms across, 0.1 mV up

In one line

A fast, regular, narrow-complex rhythm that switches on and off suddenly, usually driven by an electrical loop through or next to the AV node.1,3

Mechanism

  • "Supraventricular" means the rhythm starts above the ventricles: in the atria or the AV node. In everyday use, "SVT" usually means the paroxysmal re-entrant kinds.1,3
  • Most are caused by re-entry: an impulse circles a loop and re-excites the heart each time round, taking over as the pacemaker.1
  • AVNRT (AV nodal re-entrant tachycardia): the loop uses two pathways inside or near the AV node.3,4
  • AVRT (AV re-entrant tachycardia): the loop runs down the AV node and back up an accessory pathway, a stray muscle bridge between atria and ventricles (as in Wolff–Parkinson–White).3,4
  • Because the ventricles are activated through the normal His–Purkinje system, the QRS is narrow. The atria are activated backward at almost the same moment, so P waves are hidden in the QRS or appear just after it.1,3
  • Paroxysms start and stop suddenly, often triggered by a premature beat, and end when the heart's pacemaker shifts back to the sinus node.1

Epidemiology

  • In a US population study (Marshfield), paroxysmal SVT had a prevalence of 2.25 per 1,000 people and an incidence of 35 per 100,000 person-years.2
  • Two groups stood out: people with lone SVT (no other heart disease) were younger (mean age 37) with faster rates (mean 186 a minute), while those with other heart disease were older (mean 69) with slower rates (mean 155).2
  • In women with lone SVT, symptoms began during the childbearing years in 58%.2
  • SVT commonly affects young, otherwise healthy people and often first appears after adolescence.1

Causes and risk factors

  • A built-in circuit: dual AV nodal pathways (AVNRT) or an accessory pathway (AVRT), usually present from birth.3,4
  • Triggers: premature beats, caffeine, alcohol, stress, exertion and stimulant drugs can set off an episode in someone who already has the circuit.3
  • Other heart disease is present in many older patients.2

How to spot it

  1. Rate: usually 150–250 a minute.2,3
  2. Regularity: strikingly regular.3
  3. P waves: not visible, or seen just after the QRS as a small inverted bump.1,3
  4. QRS: narrow, unless there is a bundle branch block or conduction over an accessory pathway.3
  5. Onset and offset: abrupt, like a switch.1,3

Differential diagnosis

  • Sinus tachycardia: normal P waves before each QRS; speeds up and slows down gradually.3
  • Atrial flutter with 2:1 conduction: regular at about 150, with sawtooth flutter waves.3
  • Focal atrial tachycardia: distinct abnormal P waves before each QRS.1,3
  • Atrial fibrillation: irregularly irregular, no P waves.1
  • Ventricular tachycardia: wide QRS. A wide-complex tachycardia should be treated as VT until proven otherwise.3

Clinical picture

  • Sudden palpitations, a pounding in the neck, light-headedness, breathlessness, chest discomfort, and anxiety.1,3
  • The paroxysm can last seconds to hours, then stop as suddenly as it began.1
  • It can be very frightening but usually does no lasting harm.1

Why it matters

  • Most SVT is not dangerous but can badly affect quality of life, and it is often curable.1,3
  • SVT with an accessory pathway carries a special risk if AF develops, because the pathway can conduct very fast to the ventricles.3,4
  • Very long or frequent episodes can weaken the heart.3

Management overview

For learning only. This is the shape of care, not a treatment plan; real decisions depend on the patient and the current guideline.

  • Unstable patient: synchronized cardioversion.3,4
  • Vagal maneuvers first in a stable patient. In the REVERT trial, a modified Valsalva (strain, then lie flat with legs raised) restored sinus rhythm in 43%, against 17% with the standard Valsalva.5
  • Medicines that briefly block the AV node break most AV-node-dependent circuits when vagal maneuvers fail.3,4
  • Long term: catheter ablation is highly effective and often first-line for recurrent, symptomatic SVT; medicines are an alternative.3,4

Exam pearls

  • Narrow + regular + very fast + sudden onset = SVT until proven otherwise.1,3
  • Valsalva with a leg raise first; adenosine-type AV-nodal block next; shock if unstable.3,5
  • If it is wide, think VT first.3
  • A short PR and a delta wave on the baseline ECG point to an accessory pathway (WPW).3,4

Sources

Where this comes from.

  1. Hall JE, Hall ME. Guyton and Hall Textbook of Medical Physiology, 14th ed. Elsevier; 2021. Ch. 13 (pp. 162–163, 166).
  2. Orejarena LA, Vidaillet H, DeStefano F, et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol. 1998;31(1):150–7. doi.org/10.1016/s0735-1097(97)00422-1
  3. Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia. Circulation. 2016;133(14):e506–e574. doi.org/10.1161/CIR.0000000000000311
  4. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. Eur Heart J. 2020;41(5):655–720. doi.org/10.1093/eurheartj/ehz467
  5. Appelboam A, Reuben A, Mann C, et al. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial. Lancet. 2015;386(10005):1747–53. doi.org/10.1016/S0140-6736(15)61485-4